{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T09:57:47Z","timestamp":1753437467793,"version":"3.40.5"},"reference-count":97,"publisher":"Informa UK Limited","issue":"8","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Biological Therapy"],"published-print":{"date-parts":[[2021,8,3]]},"DOI":"10.1080\/14712598.2021.1872540","type":"journal-article","created":{"date-parts":[[2021,1,8]],"date-time":"2021-01-08T20:56:28Z","timestamp":1610139388000},"page":"1025-1034","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":6,"title":["An update on B-cell maturation antigen-targeted therapies in Multiple Myeloma"],"prefix":"10.1080","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3987-419X","authenticated-orcid":false,"given":"Massimo","family":"Martino","sequence":"first","affiliation":[{"name":"Stem Cell Transplant and Cellular Therapies Unit, Department of Hemato-Oncology and Radiotherapy, Grande Ospedale Metropolitano \u201cBianchi-Melacrino-Morelli\u201d, Reggio Calabria, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annalisa","family":"Paviglianiti","sequence":"additional","affiliation":[{"name":"Stem Cell Transplant and Cellular Therapies Unit, Department of Hemato-Oncology and Radiotherapy, Grande Ospedale Metropolitano \u201cBianchi-Melacrino-Morelli\u201d, Reggio Calabria, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2021,1,13]]},"reference":[{"key":"cit0001","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19113613"},{"key":"cit0002","doi-asserted-by":"publisher","DOI":"10.1177\/2040620716652862"},{"key":"cit0003","unstructured":"U.S. Food and Drug Administration. Daratumumab (DARZALEX). accessed 2019 Mar 21. https:\/\/www.fda.gov\/drugs\/resources-information-approved-drugs\/daratumumab-darzalex"},{"key":"cit0004","doi-asserted-by":"publisher","DOI":"10.1016\/j.beha.2020.101143"},{"key":"cit0005","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-019-0435-7"},{"key":"cit0006","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-020-00962-7"},{"key":"cit0007","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/10.11.1693"},{"key":"cit0008","doi-asserted-by":"publisher","DOI":"10.1084\/jem.192.11.1677"},{"key":"cit0009","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-06-2043"},{"key":"cit0010","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20031330"},{"key":"cit0011","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.21.12.4067-4074.2001"},{"key":"cit0012","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-12-2422"},{"key":"cit0013","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1601746"},{"key":"cit0014","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms8333"},{"key":"cit0015","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-01-691162"},{"key":"cit0016","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-15-2224"},{"key":"cit0017","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2016.150896"},{"key":"cit0018","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.13927"},{"key":"cit0019","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-09-529800"},{"key":"cit0020","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2017.02.002"},{"key":"cit0021","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.14145"},{"key":"cit0022","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-99-119190"},{"key":"cit0023","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2019.37.15_suppl.8020"},{"key":"cit0024","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2018.77.8084"},{"key":"cit0025","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2019.04.008"},{"key":"cit0026","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-020-0734-z"},{"key":"cit0027","doi-asserted-by":"publisher","DOI":"10.1158\/1541-7786.MCR-19-0582"},{"key":"cit0028","doi-asserted-by":"publisher","DOI":"10.1111\/imr.12393"},{"key":"cit0029","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-06-741058"},{"key":"cit0030","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-12-0548"},{"key":"cit0031","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-020-0427-6"},{"key":"cit0032","doi-asserted-by":"publisher","DOI":"10.2217\/fon-2020-0521"},{"key":"cit0033","unstructured":"https:\/\/www.adcreview.com\/belantamab-mafodotin-gsk2857916-clinical-trials\/"},{"key":"cit0034","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-019-0196-6"},{"key":"cit0035","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(19)30788-0"},{"key":"cit0036","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2020.38.15_suppl.8519"},{"key":"cit0037","unstructured":"Nooka AK, Mateos MV, Bahlis N, et al. DREAMM-4: evaluating safety and clinical activity of belantamab mafodotin in combination with pembrolizumab in patients with relapsed\/refractory multiple myeloma (RRMM). Hema Sphere. 2020;4(S1):433\u2013434."},{"key":"cit0038","unstructured":"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03544281"},{"key":"cit0039","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2020.38.15_suppl.8502"},{"key":"cit0040","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-018-0278-7"},{"key":"cit0041","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-020-0745-9"},{"key":"cit0042","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2020-136375"},{"key":"cit0043","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21155192"},{"key":"cit0044","unstructured":"CLINICALTRIALS.GOV-ID-NCT04036461"},{"key":"cit0045","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-020-0337-y"},{"key":"cit0046","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.02657"},{"key":"cit0047","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2019-122895"},{"key":"cit0048","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2020.03.017"},{"key":"cit0049","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020002565"},{"key":"cit0050","doi-asserted-by":"crossref","unstructured":"AMG 701 Potently Induces Anti-Multiple Myeloma (MM) Functions of T Cells and IMiDs Further Enhance Its Efficacy to Prevent MM Relapse In Vivo. Blood. 2019;134(Supplement_1):135.","DOI":"10.1182\/blood-2019-128528"},{"key":"cit0051","unstructured":"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03287908"},{"key":"cit0052","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2019-126818"},{"key":"cit0053","unstructured":"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03761108"},{"key":"cit0054","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2020-139192"},{"key":"cit0055","unstructured":"ClinicalTrials.Gov Dose Escalation Study of JNJ-64007957, a Humanized BCMA CD3 DuoBody\u00ae Antibody, in Participants With Relapsed or Refractory Multiple Myeloma (NCT03145181). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03145181"},{"key":"cit0056","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2020.38.15_suppl.100"},{"key":"cit0057","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-19-0007"},{"key":"cit0058","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-99-110427"},{"key":"cit0059","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1709866"},{"key":"cit0060","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1708566"},{"key":"cit0061","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1707447"},{"key":"cit0062","doi-asserted-by":"publisher","DOI":"10.1038\/gt.2010.21"},{"key":"cit0063","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1504542"},{"key":"cit0064","doi-asserted-by":"crossref","unstructured":"Guo B, Chen M, Han Q, et al. CD138- directed adoptive immunotherapy of chimeric antigen receptor (CAR) - modified T cells for multiple myeloma. J Cell Immunother. 2016;2(1):28\u201335.","DOI":"10.1016\/j.jocit.2014.11.001"},{"key":"cit0065","doi-asserted-by":"crossref","unstructured":"Ramos CA, Savoldo B, Torrano V, et al. Clinical responses with T lymphocytes targeting malignancy-associated \u03ba light chains. J Clin Invest. 2016;126(7):2588\u20132596.","DOI":"10.1172\/JCI86000"},{"key":"cit0066","doi-asserted-by":"publisher","DOI":"10.1089\/hum.2018.001"},{"key":"cit0067","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1817226"},{"key":"cit0068","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2020.38.15_suppl.8503"},{"key":"cit0069","unstructured":"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03090659"},{"key":"cit0070","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-018-0681-6"},{"volume-title":"61st American Society of Hematology annual meeting and exposition","year":"2019","author":"Wang B-Y","key":"cit0071"},{"key":"cit0072","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2019-121731"},{"key":"cit0073","unstructured":"PR Newswire. Janssen Announces BCMA CAR-T Therapy JNJ-4528 Granted U.S. FDA Breakthrough Therapy Designation for the Treatment of Relapsed or Refractory Multiple Myeloma. Published; December 6 2019, Accessed 2019, Dec 17. https:\/\/www.prnewswire.com\/news-releases\/janssen-announces-bcma-car-t-therapy-jnj-4528-granted-us-fda-breakthrough-therapy-designation-for-the-treatment-of-relapsed-or-refractory-multiple-myeloma-300970825.html."},{"key":"cit0074","unstructured":"Pharmaphorum. EU regulators to fast track Janssen\u2019s multiple myeloma CAR-T. Accessed 2019 Dec 17. https:\/\/pharmaphorum.com\/news\/eu-regulators-to-fast-track-janssens-multiple-myeloma-car-t\/"},{"key":"cit0075","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2020.38.15_suppl.8505"},{"key":"cit0076","unstructured":"Clinicaltrials.gov. A Study of LCAR-B38M CAR-T Cells, a Chimeric Antigen Receptor T-cell (CAR-T) Therapy Directed Against B-cell Maturation Antigen (BCMA) in Chinese Participants With Relapsed or Refractory Multiple Myeloma (CARTIFAN-1). Accessed 2019 Dec 18. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03758417"},{"key":"cit0077","unstructured":"Clinicaltrials.gov. A Study of JNJ-68284528, a Chimeric Antigen Receptor T Cell (CAR-T) Therapy Directed Against B-cell Maturation Antigen (BCMA) in Participants With Multiple Myeloma (CARTITUDE-2). Accessed 2019 Dec 18. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04133636"},{"key":"cit0078","unstructured":"Clinicaltrials.gov. A Study Comparing JNJ-68284528, a CAR-T Therapy Directed Against B-cell Maturation Antigen (BCMA), Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) or Daratumumab, Pomalidomide and Dexamethasone (DPd) in Participants With Relapsed and Lenalidomide-Refractory Multiple Myeloma (CARTITUDE-4). Accessed 2019 Dec 18. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04181827"},{"key":"cit0079","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-99-113548"},{"volume-title":"Oralpresentation #8504. ASCO Annual Meeting","year":"2020","author":"Mailankody S","key":"cit0080"},{"key":"cit0081","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-04-711903"},{"key":"cit0082","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2018.77.8084"},{"key":"cit0083","first-page":"505","volume":"130","author":"Cohen AD","year":"2017","journal-title":"Blood"},{"key":"cit0084","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-16160-5"},{"key":"cit0085","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-07-4246"},{"key":"cit0086","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-08-107292"},{"key":"cit0087","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2019-128468"},{"key":"cit0088","doi-asserted-by":"publisher","DOI":"10.1111\/imr.12920"},{"key":"cit0089","doi-asserted-by":"publisher","DOI":"10.1126\/science.aba7365"},{"issue":"1","key":"cit0090","first-page":"3","volume":"11","author":"Nejadmoghaddam MR","year":"2019","journal-title":"Avicenna J Med Biotechnol"},{"issue":"1","key":"cit0091","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1182\/blood-2018-99-109769","volume":"132","author":"Topp MS","year":"2018","journal-title":"Blood"},{"volume-title":"Poster presented at: American Association for Cancer Research Annual Meeting","year":"2018","author":"Goyos A","key":"cit0092"},{"key":"cit0093","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V128.22.2096.2096"},{"key":"cit0094","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-99-112500"},{"key":"cit0095","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2018.36.15_suppl.8034"},{"key":"cit0096","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-018-0346-9"},{"key":"cit0097","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1810060115"}],"container-title":["Expert Opinion on Biological Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14712598.2021.1872540","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,26]],"date-time":"2021-07-26T17:35:35Z","timestamp":1627320935000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14712598.2021.1872540"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,13]]},"references-count":97,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8,3]]}},"alternative-id":["10.1080\/14712598.2021.1872540"],"URL":"https:\/\/doi.org\/10.1080\/14712598.2021.1872540","relation":{},"ISSN":["1471-2598","1744-7682"],"issn-type":[{"type":"print","value":"1471-2598"},{"type":"electronic","value":"1744-7682"}],"subject":[],"published":{"date-parts":[[2021,1,13]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iebt20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iebt20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2020-10-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-01-04","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-01-13","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}